News
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
ESSA Pharma to Attend the 31st Annual ROTH Conference
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018
ESSA Appoints Otello Stampacchia, Ph.D., of Omega Funds to Board of Directors
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018